Shiladitya Sengupta, PhD
Research Awards Nationwide Recipient (2013-2015)
Brigham and Women's Hospital, Boston, MA
Funded by the American Lung Association of the Northeast
Using Nanoparticles to Improve Lung Cancer Treatment
Despite advances in molecular understanding of cancer, traditional chemotherapy still relies on highly toxic drugs as first line therapy. As such, there is an urgent need for a new approach in the management of cancer. Using tiny particles [nanoparticles] designed to hone in on specific cancers, Dr. Sengupta and team will try to attach these particles to both standard chemotherapy drugs and the new, more specific, drugs to create a novel and more effective medication.